Evidence map›Paper›PMID 24465939›Full record

ArticlePloS one2014

Liver, but not muscle, has an entrainable metabolic memory.

Sheng-Song Chen, Yolanda F Otero, Kimberly X Mulligan, Tammy M Lundblad, Phillip E Williams, Owen P McGuinness

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sheng-Song ChenDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Yolanda F OteroDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Kimberly X MulliganDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Tammy M LundbladDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Phillip E WilliamsDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Owen P McGuinnessDepartment of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee, United States of America.
Vanderbilt University · US

Funding

Vanderbilt Diabetes Research CenterP30DK020593 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI OWEN P MCGUINNESS · 2012 to 2026
$29.3M
TRANSGENIC MOUSE/ ES CELL SHARES RESOURCESP60DK020593 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1986 to 2011
$28.1M
MULTIDISCIPLINARY TRAINING IN MOLECULAR ENDOCRINOLOGYT32DK007563 · NIDDK · VANDERBILT UNIVERSITY · PI Richard M O'Brien · 1988 to 2026
$15.9M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
NUTRITION, INFECTION AND HEPATIC CARBOHYDRATE METABOLISMR01DK043748 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1997 to 2018
$7.9M
Vanderbilt Mouse Metabolic Phenotyping CenterU2CDK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2016 to 2021
$6.3M
Impact of Inflammation on the Control of Muscle Glucose UptakeR01DK078188 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 2009 to 2013
$1.7M
Nutrition Infection and Hepatic Carbohydrate MetabolismR56DK043748 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 2009 to 2009
$500k
REGULATION OF HEPATIC GLUCOSE METABOLISM IN INFECTIONR29DK043748 · NIDDK · VANDERBILT UNIVERSITY · PI MCGUINNESS, OWEN P · 1992 to 1996
–
NIDDK NIH HHS DK020593NIDDK NIH HHS DK043748NIDDK NIH HHS DK059637NIDDK NIH HHS DK07563NIDDK NIH HHS P30 DK020593NIDDK NIH HHS P60 DK020593NIDDK NIH HHS R01 DK043748NIDDK NIH HHS R01 DK078188NIDDK NIH HHS R56 DK043748NIDDK NIH HHS T32 DK007563NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Hyperglycemia in the hospitalized setting is common, especially in patients that receive nutritional support either continuously or intermittently. As the liver and muscle are the major sites of glucose disposal, we hypothesized their metabolic adaptations are sensitive to the pattern of nutrient delivery. Chronically catheterized, well-controlled depancreatized dogs were placed on one of three isocaloric diets: regular chow diet once daily (Chow) or a simple nutrient diet (ND) that was given either once daily (ND-4) or infused continuously (ND-C). Intraportal insulin was infused to maintain euglycemia. After 5 days net hepatic (NHGU) and muscle (MGU) glucose uptake and oxidation were assessed at euglycemia (120 mg/dl) and hyperglycemia (200 mg/dl) in the presence of basal insulin. While hyperglycemia increased both NHGU and MGU in Chow, NHGU was amplified in both groups receiving ND. The increase was associated with enhanced activation of glycogen synthase, glucose oxidation and suppression of pyruvate dehydrogenase kinase-4 (PDK-4). Accelerated glucose-dependent muscle glucose uptake was only evident with ND-C. This was associated with a decrease in PDK-4 expression and an increase in AMP-activated protein kinase (AMPK) phosphorylation. Interestingly, ND-C markedly increased hepatic FGF-21 expression. Thus, augmentation of carbohydrate disposal in the liver, as opposed to the muscle, is not dependent on the pattern of nutrient delivery.

Indexed as

AMP-Activated Protein KinasesAnimalsBlood GlucoseDogsEnergy MetabolismFemaleGlucagonGlycogenGlycogen SynthaseInsulinLactic AcidLipid MetabolismLiverMaleMuscle, SkeletalOxidation-ReductionAMP-Activated Protein KinasesBlood GlucoseGlucagonGlycogenGlycogen SynthaseInsulinLactic AcidProtein Serine-Threonine KinasesPyruvate Dehydrogenase Acetyl-Transferring KinasePyruvic Acid

Identifiers

PMID24465939
PMCPMC3900485
OpenAlexW1968673444

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.